I'm not going to be "shaken out". I believe that
Post# of 72440
But I do not believe that a RS to qualify for up-listing is the "boogeyman". CTIX is not like NNVC that up-listed and since then has made very little progress with its drug candidates. CTIX is the real deal and up-listing needs to occur. I believe that had we up-listed before the Russell deadline a few months ago we would now be over $8 even with a 2 for 1 RS. Mako and his friends would have had to compete with the indexes, the institutions, and the greater visibility shining on the many items of good news we have seen over the last few months. Up-listing matters more than the RS.
But then, that's JMHO...
Quote:
He's right as rain familyman. That's how they run their con. It's right out of the playbook. Don't let 'em shake you out brother.
- scgmck2